Hepatitis A vaccines are currently available to help protect patients against the infection caused by the hepatitis A virus. For instance, scientific studies with VAQTA^®* (hepatitis A vaccine, purified inactivated) have shown that 95 to 99% of patients are protected
from hepatitis A following vaccination.

This product information is intended only for residents of Canada.

*Hepatitis A vaccines are not indicated to prevent complications associated with hepatitis A.

®Registered Trademark of Merck & Co., Inc. Used under license.